Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma

著者: Joshua M. Lang, Mahazarin R. Kaikobad, Marianne Wallace, Mary Jane Staab, Dorothea Horvath, George Wilding, Glenn Liu, Jens C. Eickhoff, Douglas G. McNeel, Miroslav Malkovský - Cancer Immunology Immunotherapy 2011 被引用: 132